Get the full picture
Sign in to uncover key details.
Lion TCR
Chemicals & Related Products · Singapore · 11-50 Employees
View Company Info for Free
Overview
Headquarters
77 Ayer Rajah Cres 01-29, Singapore, Cen...Phone Number
+65 69260818Website
www.liontcr.comRevenue
<$5 MillionIndustry
About Lion TCR
Lion TCR specializes in developing innovative immunotherapies, particularly T cell receptor (TCR)-T cell therapy, to combat HBV-related hepatocellular carcinoma and other viral infections prevalent in Asia. With a focus on harnessing the patient's immune system, their proprietary therapy has demonstrated significant clinical safety and efficacy, offering improved survival rates for liver cancer patients. The company boasts the largest patented TCR library globally, covering a wide range of HLA types, and operates a state-of-the-art GMP production facility for clinical applications. Lion TCR is committed to advancing its research and clinical trials to provide personalized treatment options for patients suffering from these life-threatening conditions.Explore more
Lion TCR Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Lion TCR Tech Stack
A closer look at the technologies used by Lion TCR
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Lion TCR
Sign Up For FreeTo access detailed company insights
Lion TCR specializes in developing innovative immunotherapies, particularly T cell receptor (TCR)-T cell therapy, to combat HBV-related hepatocellular carcinoma and other viral infections prevalent in Asia. With a focus on harnessing the patient's immune system, their proprietary therapy has demonstrated significant clinical safety and efficacy, of... Read More
